Startups
Vironexis 2024-0903-
Imagine directing the liver to become a factory to crank out personalized immunotherapies for most cancers and prevent them from spreading. Vironexis came out of stealth today with FDA clearance to begin the first-ever clinical trial of an AAV-delivered cancer immunotherapy. By delivering instruc…
Team
No team members on record yet.